Camurus AB (CAMRF)
64.00
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 3.809B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -7.04% |
| Valuation | |
| PE Ratio | 52.96 |
| PE Ratio (Forward) | |
| PS Ratio | 15.85 |
| Price to Book Value | 7.876 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.0232 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 27.76% |
Profile
| Camurus AB is a research based pharmaceutical company, which engages in the research, development, and commercialization of specialty medicines. It provides its products for the treatment of severe and chronic conditions, which includes opioid dependence, pain, cancer and endocrine disorders. The company was founded by Marcus Kare Torleif Larsson in 1991 and is headquartered in Lund, Sweden. |
| URL | http://www.camurus.com |
| Investor Relations URL | N/A |
| HQ State/Province | Skane |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Growth |
| Next Earnings Release | Nov. 05, 2026 |
| Last Earnings Release | Jul. 15, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Camurus AB is a research based pharmaceutical company, which engages in the research, development, and commercialization of specialty medicines. It provides its products for the treatment of severe and chronic conditions, which includes opioid dependence, pain, cancer and endocrine disorders. The company was founded by Marcus Kare Torleif Larsson in 1991 and is headquartered in Lund, Sweden. |
| URL | http://www.camurus.com |
| Investor Relations URL | N/A |
| HQ State/Province | Skane |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Growth |
| Next Earnings Release | Nov. 05, 2026 |
| Last Earnings Release | Jul. 15, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |